Vermillion & White Wealth Management Group LLC acquired a new stake in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,300 shares of the biotechnology company’s stock, valued at […]
Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) was upgraded by StockNews.com to a “sell” rating in a research report issued on Thursday. Several other analysts have also commented on LXRX. Leerink Partnrs reiterated an “outperform” rating on shares of Lexicon Pharmaceuticals in a report on Tuesday, April 30th. Needham & Company LLC reissued a “hold” […]
Platform Technology Partners lessened its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 3.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,377 shares of the pharmaceutical company’s stock after selling 50 shares during […]
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) shares dropped 8.8% during trading on Tuesday . The company traded as low as $79.97 and last traded at $80.21. Approximately 82,870 shares were traded during trading, a decline of 47% from the average daily volume of 156,157 shares. The stock had previously closed at $87.91. Analysts […]
Shares of CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Free Report) are set to reverse split before the market opens on Wednesday, June 5th. The 1-50 reverse split was announced on Wednesday, June 5th. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, June 5th. CNS Pharmaceuticals Stock Down 39.9 […]